Skip to main content

Table 1 Participant characteristics (n = 411)

From: Medication-related problems identified by community pharmacists: a descriptive case study of two Australian populations

Characteristics

IMeRSea (n = 255)

n (%)

PharMIbridgeb (n = 156)

n (%)

Age, years, mean (SD)

60.0 (11.7)

48.1 (12.6)

Age group in years

  

 < 45

21 (8.2)

62 (39.7)

 45–54

58 (22.8)

44 (28.2)

 55–64

83 (32.6)

37 (23.7)

 65–74

66 (25.9)

10 (6.4)

 ≥ 75

27 (10.6)

3 (1.9)

Gender

  

 Male

95 (37.3)

69 (44.2)

 Female

160 (62.8)

85 (54.5)

 Not specified

2 (1.3)

Cultural identity

  

 Aboriginal

236 (92.5)

8 (5.1)

 Torres Strait Islander

2 (0.8)

 Both

5 (2.0)

 Neither

137 (87.8)

 Not specified

12 (4.7)

11 (7.1)

Locationc

  

 Urban/metropolitan

59 (23.1)

87 (55.8)

 Rural/remote/non-metropolitan

196 (76.9)

69 (44.2)

Self-reported general health

  

 Excellent

10 (4.1)

3 (1.9)

 Very good

44 (18.1)

27 (17.4)

 Good

112 (46.1)

66 (42.6)

 Fair

59 (24.3)

40 (25.8)

 Poor

18 (7.4)

19 (12.3)

 Number of self-reported chronic conditions, median (IQR)

6 (4)

1 (3)d

 Number of medications, median (IQR)

7 (6)

6 (4)

  1. aNumber of participants who received a Medicines Talk service
  2. bNumber of participants who received a PharMIbridge initial intervention service (Initial Health Review)
  3. cIn the IMeRSe feasibility study, location was classified using the Pharmacy Accessibility and Remoteness Index of Australia 2018–2019 [50]; in the PharMIbridge RCT, location was classified using the Modified Monash Model [51]
  4. dExcludes mental illnesses